Skip to main content
. 2023 Jun 26;14:1183101. doi: 10.3389/fphys.2023.1183101

FIGURE 1.

FIGURE 1

Full-length dystrophin and representative truncated dystrophins currently in use in clinical trials. (A) Full-length dystrophin versus (B) the truncated dystrophin constructs: i) mini-dystrophin Δ3990, ii) microdystrophin ΔR4-23/ΔCT (µDysH2) and iii) microdystrophin μDys-5R. Domains are identified as the N-terminal actin-binding domain, 1–24 spectrin-like repeats, four hinges (H1–H4), a cysteine-rich domain, and a C-terminal domain (CTD). The nNOS-binding domain is shown by the red numbers (repeats 16 and 17).